- Home
- MHH vs IBIO Comparison
MHH vs IBIO Comparison
Compare MHH & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | IBIO |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 83.5M |
| IPO Year | 2008 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MHH | IBIO |
|---|---|---|
| Price | $6.99 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $5.69 |
| AVG Volume (30 Days) | 5.4K | ★ 504.1K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.71 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $191,371,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.86 | N/A |
| P/E Ratio | $726.99 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.51 | $0.78 |
| 52 Week High | $8.37 | $3.82 |
Technical Indicators
Market Signals| Indicator | MHH | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 30.69 |
| Support Level | $6.87 | N/A |
| Resistance Level | $7.29 | $1.52 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 0.00 | 6.90 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.